Etoposide 100 mg/5 ml concentrat pentru soluţie perfuzabilă 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

etoposide 100 mg/5 ml concentrat pentru soluţie perfuzabilă

naprod life sciences private limited - etoposidum - concentrat pentru soluţie perfuzabilă - 100 mg/5 ml

Etoposide solutie injectabila 100 mg/5 ml 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

etoposide solutie injectabila 100 mg/5 ml

neon laboratories limited - etoposidum - solutie injectabila - 100 mg/5 ml

Imfinzi 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - carcinom, pulmonar non-celulă mică - agenți antineoplazici - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Kepivance 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

kepivance

swedish orphan biovitrum ab (publ) - palifermin - mucozita - toate celelalte produse terapeutice - kepivance este indicat pentru a reduce incidenţa, durata şi severitatea mucositis orale la pacienţii adulţi cu tumori maligne hematologice primirea myeloablative radiochemotherapy asociate cu o incidenţă ridicată de mucositis severă şi care necesită suport autologe-hematopoietică-celule stem.

VEPESID 100 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vepesid 100 mg

corden pharma latina s.p.a. - italia - etoposidum - caps. moi - 100mg - alcaloizi din plante si alte produse naturale derivati de podophyllotoxina

VEPESID 50 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vepesid 50 mg

corden pharma latina s.p.a. - italia - etoposidum - caps. moi - 50mg - alcaloizi din plante si alte produse naturale derivati de podophyllotoxina

EQUORAL® 25 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

equoral® 25 mg

teva czech industries s.r.o - ciclosporinum - caps. moi - 25mg - imunosupresoare inhibitori de calcineurina

EQUORAL® 50 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

equoral® 50 mg

teva czech industries s.r.o - ciclosporinum - caps. moi - 50mg - imunosupresoare inhibitori de calcineurina

EQUORAL® 100 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

equoral® 100 mg

teva czech industries s.r.o - ciclosporinum - caps. moi - 100mg - imunosupresoare inhibitori de calcineurina

Lysodren 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

lysodren

hra pharma rare diseases - mitotan - corpul adrenal neoplasmelor - agenți antineoplazici - tratamentul simptomatic al carcinomului corticosuprarenalian avansat (inoperabil, metastatic sau recidivat). efectul de lysodren pe non-funcționale carcinomului cortical suprarenal nu este stabilit.